Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Follow-up Study for Subjects With Chronic Hepatitis B Previously Treated With Imdusiran (AB-729)

NCT06277037 is registered in ClinicalTrials.gov with Arbutus Biopharma Corporation as lead sponsor.

NCT NCT06277037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06277037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Follow-up Study for Subjects With Chronic Hepatitis B Previously Treated With Imdusiran (AB-729)
Lead sponsor
Arbutus Biopharma Corporation
Phase
Observational
Overall status
Recruiting
Start date
July 11, 2024
Completion date
October 30, 2029
Enrollment
50 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

long term follow-up